Cost and controversy are limiting use of new Alzheimer’s drug
(By Jon Hamilton for NPR) The new Alzheimer’s drug Aduhelm isn’t reaching many patients. And doctors say reasons include its
Read moreA trusted source for Medicare news and education from the AMAC Foundation.
(By Jon Hamilton for NPR) The new Alzheimer’s drug Aduhelm isn’t reaching many patients. And doctors say reasons include its
Read more(By Matthew Herper for ST A T) A n experimental antiviral pill developed by Pfizer reduced the risk of death
Read more(By Jaclyn Diaz for NPR) The chief law enforcement officials for Kentucky, Tennessee and Ohio are challenging the Biden administration’s
Read more(By Judith Graham for Kaiser Health News) Earlier this year, the World Health Organization announced a global campaign to combat
Read more(By Rachana Pradhan for Kaiser Health News) President Joe Biden’s mammoth domestic spending bill would add hearing benefits to the
Read more(Source - Kaiser Family Foundation published November 2, 2021) A record 3,834 Medicare Advantage plans will be available across the
Read more(By Meredith Freed , Anthony Damico , and Tricia Neuman for Kaiser Family Foundation published November 2, 2021) Over the
Read more(By Julie Appleby for Kaiser Health News) Trendy-looking websites promise convenience and freedom from networks, at far less than the
Read more(Source - blogs.va.gov) Heart failure affects around 6.2 million adults in the United States and is one of the leading
Read more(By Nick Moran for Becker’s Hospital Review ) A survey from Hint Health, a direct primary care management platform, found
Read more